Ab&B Bio-Tech, a Taizhou-based listed biopharmaceutical company, has signed an exclusive agreement for overseas expansion with Walvax Hong Kong, a wholly owned subsidiary of the leading Chinese vaccine producer Walvax.

Ten enterprises from Taizhou have been newly certified under the 2025 "Jiangsu Premium" program, marking a new milestone in local brand development.

Taizhou's innovation-driven manufacturing sector continues to rise.

Taizhou has been actively working to improve its business environment in recent years, creating favorable conditions for enterprises to grow and succeed.

Taizhou's foreign trade showed notable improvement in August, with total imports and exports reaching $2.21 billion, up 16.4 percent year-on-year and ranking second in the province.

A joint supervision mechanism for special goods entering and leaving the country was recently implemented in the Taizhou Medical High-tech Zone.

The Jiangmen Underground Neutrino Observatory, a major scientific facility led by the Institute of High Energy Physics of the Chinese Academy of Sciences, began operating on Aug 26 in Jiangmen, Guangdong province.

Taizhou's financial sector delivered strong results in the first half of 2025, according to official statistics.